These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 23662445)
21. On-column refolding purification of DT389-hIL13 recombinant protein expressed in Escherichia coli. Sun W; Dai X; Zheng Y; Wang J; Hou L; Du J; Hu HG Protein Expr Purif; 2011 Jan; 75(1):83-8. PubMed ID: 20851185 [TBL] [Abstract][Full Text] [Related]
22. Techno-economic evaluation of an inclusion body solubilization and recombinant protein refolding process. Freydell EJ; van der Wielen LA; Eppink MH; Ottens M Biotechnol Prog; 2011; 27(5):1315-28. PubMed ID: 21674819 [TBL] [Abstract][Full Text] [Related]
23. Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli. Chen H; Li N; Xie Y; Jiang H; Yang X; Cagliero C; Shi S; Zhu C; Luo H; Chen J; Zhang L; Zhao M; Feng L; Lu H; Zhu J Appl Microbiol Biotechnol; 2017 Jul; 101(13):5267-5278. PubMed ID: 28391504 [TBL] [Abstract][Full Text] [Related]
24. Expression, purification, refolding and in vitro recovery of active full length recombinant human gelatinase MMP-9 in Escherichia coli. Mohseni S; Moghadam TT; Dabirmanesh B; Khajeh K Protein Expr Purif; 2016 Oct; 126():42-48. PubMed ID: 27164034 [TBL] [Abstract][Full Text] [Related]
25. Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli. Srivastava P; Bhattacharaya P; Pandey G; Mukherjee KJ Protein Expr Purif; 2005 Jun; 41(2):313-22. PubMed ID: 15866717 [TBL] [Abstract][Full Text] [Related]
26. An automatic refolding apparatus for preparative-scale protein production. Feng Y; Zhang M; Zhang L; Zhang T; Ding J; Zhuang Y; Wang X; Yang Z PLoS One; 2012; 7(9):e45891. PubMed ID: 23029296 [TBL] [Abstract][Full Text] [Related]
27. Inclusion body purification and protein refolding using microfiltration and size exclusion chromatography. Batas B; Schiraldi C; Chaudhuri JB J Biotechnol; 1999 Feb; 68(2-3):149-58. PubMed ID: 10194854 [TBL] [Abstract][Full Text] [Related]
28. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2. Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092 [TBL] [Abstract][Full Text] [Related]
29. Lysozyme refolding at high concentration by dilution and size-exclusion chromatography. Goa YG; Guan YX; Yao SJ; Cho MG J Zhejiang Univ Sci; 2003; 4(2):136-41. PubMed ID: 12659225 [TBL] [Abstract][Full Text] [Related]
30. Comparing the refolding and reoxidation of recombinant porcine growth hormone from a urea denatured state and from Escherichia coli inclusion bodies. Cardamone M; Puri NK; Brandon MR Biochemistry; 1995 May; 34(17):5773-94. PubMed ID: 7727438 [TBL] [Abstract][Full Text] [Related]
31. Refolding and purification of recombinant human (Pro)renin receptor from Escherichia coli by ion exchange chromatography. Wang F; Guo J; Bai Q; Wang L Biotechnol Prog; 2014; 30(4):864-71. PubMed ID: 24723509 [TBL] [Abstract][Full Text] [Related]
32. [Site-directed mutation of PoIFN-alpha and its expression in Escherichia coli]. Chen T; Yu RS; Liu HL; Li Z; Cao XR Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):339-42. PubMed ID: 12192870 [TBL] [Abstract][Full Text] [Related]
33. Effect of column dimensions and flow rates on size-exclusion refolding of beta-lactamase. Harrowing SR; Chaudhuri JB J Biochem Biophys Methods; 2003 Jun; 56(1-3):177-88. PubMed ID: 12834976 [TBL] [Abstract][Full Text] [Related]
34. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis. Afzal AJ; Lightfoot DA Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130 [TBL] [Abstract][Full Text] [Related]
35. Expression, purification, and characterization of recombinant human consensus interferon-alpha in Escherichia coli under λP(L) promoter. Mohammed Y; El-Baky NA; Redwan EM Prep Biochem Biotechnol; 2012; 42(5):426-47. PubMed ID: 22897766 [TBL] [Abstract][Full Text] [Related]
36. [Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist]. Li S; Deng X; Zhao H; Huang X; Yu T; Cheng Y; Dan G Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1128-32. PubMed ID: 18027711 [TBL] [Abstract][Full Text] [Related]
37. [Optimization of induction and purification of HIV-1 Gag protein in Escherichia coli expression system]. Fu J; Sun J; Chen P; Huo Z; Hao Y; Liu Y Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1306-11. PubMed ID: 18837413 [TBL] [Abstract][Full Text] [Related]
38. In vitro protein refolding by chromatographic procedures. Li M; Su ZG; Janson JC Protein Expr Purif; 2004 Jan; 33(1):1-10. PubMed ID: 14680955 [TBL] [Abstract][Full Text] [Related]
39. Improving the refolding efficiency for proinsulin aspart inclusion body with optimized buffer compositions. Chen Y; Wang Q; Zhang C; Li X; Gao Q; Dong C; Liu Y; Su Z Protein Expr Purif; 2016 Jun; 122():1-7. PubMed ID: 26826314 [TBL] [Abstract][Full Text] [Related]
40. On-column refolding of recombinant human interferon-gamma with an immobilized chaperone fragment. Gao YG; Guan YX; Yao SJ; Cho MG Biotechnol Prog; 2003; 19(3):915-20. PubMed ID: 12790657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]